Bionaturis is actively seeking in-licensing opportunities and strategic alliances to bring new premium applications to the animal health marketplace.

Our main areas of interest are:

  • New generation vaccines strategies
  • Unique feed supplements and non-prescription products for pets
  • Disruptive technologies for animal health applications

At the same time, the B2B business model of Bionaturis is based on development, registration, commercialization, and distribution out-licensing agreements with tier-1 and tier-2 animal health companies.

To know more about licensing options, please check the “products“ and “platforms“ tabs or email your enquiry to